Katsuyuki Sakanaka, Keita Sasaki, Takahiro Tsushima, Ryunosuke Machida, Yoichi Hamai, Akinori Watanabe, Kota Kawabata, Satoru Matsuda, Ken Kato, Haruhiko Fukuda, Hiroya Takeuchi. "Randomized controlled phase II trial comparing nivolumab, ipilimumab plus radiotherapy versus nivolumab plus ipilimumab for metastatic or recurrent esophageal cancer: Japan Clinical Oncology Group study JCOG2311 (ART NOUVEAU).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps461